You getting your panties wet too because of that mouse pic? Lol
Last edited:
dNovo new promissing player in the stemcell race
- Thread starter byebyehair
- Start date
Just inject it in muh head, I'll test it.... wot else they need to do? they just need to see if it works on a human, just inject it and within 7 months u have result then all bald men in world can be as hairy as they want to be if they can afford it.
- Reaction score
- 188
- Reaction score
- 481
Human Hair Stem Cells Generated Using dNovo’s Proprietary Direct Reprogramming Technology (Patent-Pending)
Our first objective was to generate personalized hair stem cells using our direct reprogramming technology. In 2019, we were successful in putting together our direct reprogramming system to generate human hair stem cells (patent pending). These reprogrammed human cells successfully reactivated the genetic circuitry of native hair stem cells. They also performed biochemically as expected of native hair stem cells. After demonstrating this breakthrough, we sought to validate the functionality of our newly reprogrammed human hair stem cells.
Human Dermal Papilla Cells Generated Using dNovo’s Proprietary Direct Reprogramming Technology (Patent-Pending)
Dermal papilla cells are another important component of the hair follicle. These cells serve as the signaling center for hair stem cells and promote robust hair growth. In certain cases where the entire hair follicle is depleted, dermal papilla cells are also lost, and so we sought to generate these cells with our direct reprogramming technology. We have now successfully developed the reprogramming system to generate these human dermal papilla cells (patent pending). Our reprogrammed dermal papilla cells successfully reactivate the native genetic circuitry and perform biochemically as expected of human dermal papilla cells.
So, they have 2 patents. How long it will take to approve patents to some biomedical company? Like I see they are waiting to approve their patent from Q3 2019.
Google is your friend. On average 22 months according to the USPTO but I wouldn't be surprised if it took a lot more time with COVID delays.
It's been more than 2 years now.
I'm actually pretty excited about this. It would be cheaper and easier than Tsuji or Stemson, and has the potential to reverse balding just as well if their reprogramming is as successful as claimed, which it seems to be.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621486/
We can already largely remove the underlying cause of DP cell depletion with dutasteride and AR antagonists.
I'm actually pretty excited about this. It would be cheaper and easier than Tsuji or Stemson, and has the potential to reverse balding just as well if their reprogramming is as successful as claimed, which it seems to be.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621486/
We can already largely remove the underlying cause of DP cell depletion with dutasteride and AR antagonists.
Last edited:
You guys never learn. Every company is ultra optimistic and look like they have cracked it when they are in the mouse stage: it was like that with tsuji (remember the press release about the partnership with Kyocera with pictures of the event) and Stemson (in the beginning they believed they would be doing clinical trials by 2020-2021 already or something like that).
But then when they move from proof of concept to actual pre clinical research things get MUCH more complicated. Organ/Tsuji went bust and Stemson, while still being able to make progress and raise additional funds, missed their initial deadlines and have a much more sober discourse now.
But you guys never learn. Every company that releases a mouse picture showing hair alongside some bold claims will still get your panties wet.
In the end we are all craving for something to work so I can understand that. But I put much more value in a company that is already doing actual pre clinical research versus a 3
people company that is in hype mode with just a mouse pic and some marketing buzzwords to show.
But then when they move from proof of concept to actual pre clinical research things get MUCH more complicated. Organ/Tsuji went bust and Stemson, while still being able to make progress and raise additional funds, missed their initial deadlines and have a much more sober discourse now.
But you guys never learn. Every company that releases a mouse picture showing hair alongside some bold claims will still get your panties wet.
In the end we are all craving for something to work so I can understand that. But I put much more value in a company that is already doing actual pre clinical research versus a 3
people company that is in hype mode with just a mouse pic and some marketing buzzwords to show.
Last edited:
If dNovo’s approach is so much better/simple WHY did it take so much for them to raise seed capital despite being founded in 2018?
They were founded in the same year as Stemson but they are at least 2 years behind them, why?
You guys need some common sense.
Do you guys realize this company was founded in 2018 and are still talking about their proof of concept findings? If their approach is so much better then why are them so behind the curve on termos of research and funding?
They were founded in the same year as Stemson but they are at least 2 years behind them, why?
You guys need some common sense.
Do you guys realize this company was founded in 2018 and are still talking about their proof of concept findings? If their approach is so much better then why are them so behind the curve on termos of research and funding?
I swear alexy is your dad
You guys are the ones that brought Stemson’s name in this thread. And I’m not even praising them. I think Stemson is late, but dNevo is even more late since they were founded in the same year as Stemson and are behind them in every main metric (stage of research, funds raised, company size etc.)
I don't disagree with that, but they aren't that far behind, and this would be affordable for more people. I don't think it would cost more than 10k
Last edited:
You are basing this assumption on what? Maybe I missed some articles about them?
Just because the press releases about dNovo (and their own website) are making their treatment ***seem* simple, we don’t really know much about how their approach really works because they haven’t shared much actual technical information.
Their website basically consists of a mouse pic and an infographic done for the average lay man - written basically like marketing/sales pitch
Their website basically consists of a mouse pic and an infographic done for the average lay man - written basically like marketing/sales pitch
such a price would be very advantageous, but I have a question why would it be so cheap?
Because people here read press relasses written by marketing agencies that make their panties wet and then start making ultra optimistic and baseless extrapolations